Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant’s drug is for ulcerative colitis and Crohn’s disease. As many as two million people in the U.S. suffer from the disorders. Roivant Sciences, a biotech company started by Republican presidential candidate Vivek Ramaswamy , is in talks to sell an experimental drug for a debilitating stomach…
#crohn #roivantsciences #vivekramaswamy #rocheholding